BBV154

DAILY NEWS ANALYSIS (UPSC) |26 Jan 2021| RaghukulCS

Intranasal Covid-19 vaccine, BBV154 Context: An expert body looking into Bharat Biotech’s application for testing its proposed single-dose intranasal Covid-19 vaccine, BBV154, has asked it to revise its protocol to conduct clinical trials. Topic in the syllabus: Prelims – Science & technology What is an intranasal vaccine? Vaccines are most commonly administered as injectable shots